Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Talis Biomedical Corporation (TLIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.8350+0.0230 (+2.83%)
At close: 04:00PM EDT
0.8200 -0.01 (-1.80%)
After hours: 07:51PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.8120
Open0.8200
Bid0.8300 x 1800
Ask0.8700 x 1300
Day's Range0.8111 - 0.8472
52 Week Range0.8000 - 12.8800
Volume71,252
Avg. Volume181,432
Market Cap22.227M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TLIS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Talis Biomedical Corporation
    Daily – Vickers Top Buyers & Sellers for 05/19/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • GlobeNewswire

    Talis Biomedical Announces First Quarter 2022 Financial Results

    Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the first quarter ended March 31, 2022. Business update Completed assessment of manufacturing processes and product design for manufac

  • GlobeNewswire

    Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022

    MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will report first quarter financial results on Tuesday, May 10, 2022, after market close. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Ti

  • GlobeNewswire

    Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

    Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2021. Talis has not started its phased launch of

Advertisement
Advertisement